RecruitingNot ApplicableNCT05794087

The Role of Macrophage Activation in Lung Injury Following Ozone Exposure

Activated Macrophages and Ozone Toxicity II


Sponsor

Rutgers, The State University of New Jersey

Enrollment

120 participants

Start Date

Feb 7, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of the study is to better understand the mechanisms of lung injury from ozone exposure. Subjects will participate in two exposure sessions: filtered air and 0.2 ppm ozone. The exposure visits will be at least 2 weeks apart. Subjects will be asked to produce sputum through coughing after each exposure. The samples will be analyzed for macrophage activity.


Eligibility

Min Age: 18 YearsMax Age: 40 Years

Exclusion Criteria10

  • Cardiovascular disease
  • Respiratory disease
  • Recent (within 4 weeks) respiratory or COVID-19 symptoms
  • Diabetes
  • Pregnancy
  • HIV Infection
  • History of smoking within the past 5 years.
  • Orthopedic or rheumatologic conditions which would interfere with cycle use
  • Inability to produce a sputum plug at screening
  • Daily use of antioxidant supplements, excluding those in a multivitamin. These supplements include Vitamin C or E, selenium, beta-carotene, lycopene, lutein, zeaxanthin and ginkgo biloba. Supplements taken less frequently but at least once a week will be reviewed by the principal investigator for eligibility determination.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERClean Air

Subjects will be exposed to clean air for 3 hours.

OTHEROzone

Subjects will be exposed to 0.2 ppm ozone for 3 hours.


Locations(1)

Rutgers - EOHSI

Piscataway, New Jersey, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05794087


Related Trials